Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q4 2023
Institutional positions in Jasper Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +1 vs. Q3 2023
- Shares held
- 75.5M
- −16.1M (−17.5%) vs. Q3 2023
- Total value
- $61.2M
- −$2.54M (−4.0%) vs. Q3 2023
- New holders
- 9
- 11 more added
- Sold out
- 8
- 9 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 11,219,036 | $8.55M | 6.06% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 9,870,980 | $7.79M | 0.86% | +1,570,000+18.9% | Added |
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $6.72M | 6.16% | 00.0% | Unchanged |
| Carlyle Group Inc. | 8,761,891 | $6.67M | 0.32% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 713,063 | $5.63M | 1.04% | −4,974,071−87.5% | Reduced |
| Octagon Capital Advisors LP | 4,468,114 | $3.53M | 0.56% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,092,958 | $3.23M | 0.00% | +300,000+7.9% | Added |
| Opaleye Management Inc. | 3,985,340 | $3.14M | 0.84% | +3,985,340 | New |
| Kingdon Capital Management, L.L.C. | 3,540,000 | $2.79M | 0.53% | +500,000+16.4% | Added |
| Bank of America Corp | 3,180,059 | $2.51M | 0.00% | −2420.0% | Reduced |
| Nantahala Capital Management, LLC | 2,228,265 | $1.76M | 0.18% | −174,639−7.3% | Reduced |
| Woodline Partners LP | 1,732,993 | $1.37M | 0.01% | −1,267,007−42.2% | Reduced |
| Morgan Stanley | 1,699,550 | $1.34M | 0.00% | +918,671+117.6% | Added |
| Saturn V Capital Management LLC | 1,386,215 | $1.09M | 0.42% | −800−0.1% | Reduced |
| BlackRock Inc. | 1,323,972 | $1.04M | 0.00% | +3,188+0.2% | Added |
| Geode Capital Management, LLC | 904,477 | $713.8K | 0.00% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 789,331 | $622.8K | 0.06% | +789,331 | New |
| Mariner, LLC | 590,510 | $465.9K | 0.00% | −62,239−9.5% | Reduced |
| Renaissance Technologies LLC | 514,324 | $406.0K | 0.00% | +204,112+65.8% | Added |
| Fernwood Investment Management, LLC | 494,706 | $390.3K | 0.13% | +40,000+8.8% | Added |
| Bank of Montreal | 348,300 | $278.6K | 0.00% | +348,300 | New |
| Monaco Asset Management SAM | 249,563 | $196.9K | 0.08% | +249,563 | New |
| State Street Corp | 229,994 | $181.5K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 200,000 | $157.8K | 0.01% | −393−0.2% | Reduced |
| Citadel Advisors LLC | 191,155 | $150.8K | 0.00% | +112,829+144.1% | Added |
| Northern Trust Corp | 154,909 | $122.2K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 129,883 | $102.5K | 0.00% | +67,575+108.5% | Added |
| Summit Trail Advisors, LLC | 65,000 | $51.3K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 54,500 | $43.0K | 0.00% | +54,500 | New |
| Two Sigma Investments, LP | 54,168 | $42.7K | 0.00% | −11,925−18.0% | Reduced |
| Bank of New York Mellon Corp | 43,593 | $34.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 36,899 | $29.1K | 0.00% | 00.0% | Unchanged |
| Gries Financial LLC | 23,845 | $18.8K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 11,209 | $8.84K | 0.00% | +11,209 | New |
| Tower Research Capital LLC (TRC) | 11,144 | $8.79K | 0.00% | +11,144 | New |
| Lazard Asset Management LLC | 11,500 | $8.00K | 0.00% | +360+3.2% | Added |
| Wells Fargo & Company | 609 | $481 | 0.00% | −140−18.7% | Reduced |
| Group One Trading, L.P. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,200 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 257 | $0 | 0.00% | +257 | New |
| Simplex Trading, LLC | 26 | $0 | 0.00% | +26 | New |
| Ally Bridge Group (NY) LLC | 3,659,255 | – | – | +515,091+16.4% | Added |
| BVF Inc | 0 | $0 | 0.00% | −9,900,000−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −4,500,217−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −2,868,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −1,125,087−100.0% | Sold out |
| Scoggin Management LP | 0 | $0 | 0.00% | −508,045−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −233,159−100.0% | Sold out |
| Forefront Analytics, LLC | 0 | $0 | 0.00% | −110,792−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |